Exosome Analytics offers a platform for sensitive protein marker profiling on extracellular vesicles (EVs). Their technology enables non-invasive diagnostic tools for early cancer detection and tumor profiling by analyzing EV-associated histological markers.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for detecting and profiling cancer often rely on invasive procedures or lack the sensitivity to identify disease at its earliest stages. This can lead to delayed diagnoses, reduced treatment efficacy, and poorer patient outcomes.
Solution
Exosome Analytics provides a platform for highly sensitive protein marker profiling on extracellular vesicles (EVs). Our technology enables the development of diagnostic tools for early cancer detection and tumor profiling by analyzing specific histological markers present on EVs. This approach offers a non-invasive method to identify and characterize disease, facilitating personalized medicine strategies.
Target Audience
Our primary customers are clinical diagnostic laboratories, research institutions, and pharmaceutical companies focused on oncology and biomarker discovery.
Features
- Extracellular vesicle (EV) isolation and purification kits for sample preparation.
- Proprietary immunoassay technology for sensitive detection of EV-associated protein biomarkers.
- Quantitative analysis of protein expression levels on EVs.
- Workflow designed for the identification of histological markers indicative of specific cancer types.
- Platform compatibility with standard laboratory instrumentation.